Assessment of genomic alterations in adenosquamous carcinoma of the pancreas (ASCOP).
Jordan E, Basturk O, Leach S, Klimstra D, Allen P, Berger M, Askan G, Yu K, O'Reilly E, Lowery M. Assessment of genomic alterations in adenosquamous carcinoma of the pancreas (ASCOP). Journal Of Clinical Oncology 2016, 34: 261-261. DOI: 10.1200/jco.2016.34.4_suppl.261.Peer-Reviewed Original ResearchRecurrence-free intervalOverall survivalMolecular profilingStage IV diseaseNext generation sequencing assayComprehensive molecular profilingAssessment of genomic alterationsCohort of patientsReview clinical characteristicsCopy number aberrationsExocrine pancreatic cancerTargeted deep sequencingMedian OSMedian PFSResected ptsTP53-MUTMedian followAdenosquamous carcinomaIV diseaseLine therapySurgical resectionRare subtypeSquamous componentClinicopathological dataKRAS mutations
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply